Biomarkers and efficacy: are we nearly there yet?
- PMID: 21551003
- DOI: 10.1093/annonc/mdr258
Biomarkers and efficacy: are we nearly there yet?
Comment on
-
Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.Ann Oncol. 2011 Jul;22(7):1535-1546. doi: 10.1093/annonc/mdq632. Epub 2011 Jan 12. Ann Oncol. 2011. PMID: 21228335 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous